RXST 241018 47.50P (RXST241018P47500) Stock Options, News & Quotes

US OptionsDetailed Quotes

RXST241018P47500

Watchlist

1.00
0.000.00%

15min DelayTrading Sep 24 10:36 ET

0.00High0.00Low

Intraday

5D
Daily

News

The Top Five Long Crowded Stocks in Each U.S. Sector
Seeking AlphaSep 24 12:13 ET
RxSight Executive Sells Over $328k in Company Stock
InvestingSep 23 18:52 ET
BTIG Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $59
Moomoo NewsSep 23 06:31 ET · Ratings
Here's Why We're Not At All Concerned With RxSight's (NASDAQ:RXST) Cash Burn Situation
Yahoo FinanceSep 18 06:20 ET
Peeling Back The Layers: Exploring RxSight Through Analyst Insights
BenzingaSep 13 08:00 ET
Needham Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $66
Moomoo NewsSep 13 07:33 ET · Ratings

Comments

Meltyy

May 16 14:19

🔔 RA Capital Q1 ‘24* Holdings Released... 🐳

» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$
...

Moomoo AI

Feb 5 18:22

The recent insider sale of RxSight shares and the absence of insider purchases over the last year raise concerns about the company's outlook. Despite significant insider ownership, the lack of insider buying does not inspire confidence in the company's prospects.

Trade Alert: Independent Director Of RxSight William Link Has Sold Stock

FlexibleTrader

Jan 9 04:23

$RxSight (RXST.US)$ oww back in action now sold too early

FlexibleTrader

Dec 16, 2023 08:26

$RxSight (RXST.US)$ 213 % runs looks good here priming to jump 🔥

FlexibleTrader

Dec 15, 2023 02:38

$RxSight (RXST.US)$ bought few lets fo !